Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Aug 7, 2024
SAN CARLOS, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the second quarter ended June 30, 2024.
